|Bid||43.14 x 4000|
|Ask||0.00 x 3200|
|Day's Range||43.11 - 43.91|
|52 Week Range||36.74 - 51.53|
|Beta (3Y Monthly)||1.32|
|PE Ratio (TTM)||9.27|
|Earnings Date||Jul 16, 2019 - Jul 22, 2019|
|Forward Dividend & Yield||1.20 (2.77%)|
|1y Target Est||54.24|
(Bloomberg) -- As 2019’s bumper crop of initial public offerings either languishes or wildly exceeds expectations, Slack Technologies Inc. is taking a route to the trading floor that it hopes will yield a much more boring outcome.Following in the footsteps of music-streaming service Spotify Technology SA last year, the workplace messaging application is set to start trading on the New York Stock Exchange Thursday via a direct listing. It’s just the second large company to test the unusual method and will be closely watched by other potential candidates to see how successfully the company and its advisers pull it off.Investors got their first hint of how things are going when Slack’s reference price was set at $26 per share on Wednesday. Unlike the offering price paid by investors in a traditional IPO, the reference price doesn’t establish the valuation, though it’s partly based on recent trading in private markets. Its main purpose is to provide a starting point to allow trading to begin under New York Stock Exchange rules.With IPO heavyweight advisers from Goldman Sachs Group Inc., Morgan Stanley and Allen & Co. helping to steer Slack through its listing alongside market maker Citadel Securities, all eyes will be on how the first day of trading plays out. But the company and its investors aren’t looking for a meaningful stock pop -- and want to avoid the volatility -- that often accompanies high-profile share sales, according to a person familiar with the process.On Wednesday, Slack said that its investors had converted additional Class B stock to Class A shares, increasing the number that could be sold to 194 million from 181 million, out of a total of 504.4 million. Especially because there’s no lock-up period, there’s a risk of too few investors wanting to buy or too many wanting to sell.“A direct listing can be considered risky for a variety of reasons," Alejandro Ortiz, an analyst at SharesPost, said in a note. “There is an increased chance of substantially more supply than demand for Slack’s shares. All of this could result in heightened volatility in the early hours and days of trading.”Reference PriceFifteen months after its own direct listing, Spotify trades about 12% above its reference price of $132, at about $148 a share on Wednesday. That’s well below where the stock opened on its first day of trading in April 2018, though, at $165.90 apiece.On Thursday, much of the attention at the exchange will be focused on one man. Pete Giacchi, a longtime market maker at the NYSE for Citadel Securities, will be tasked with opening the stock –- just as he was for Uber Technologies Inc.’s listing in May, people with knowledge of the matter said. It could be a long wait: Spotify’s shares took more than three hours to start trading, and it will take a while to make sure that the pricing and trading volumes coming in are at levels that Slack and its advisers are comfortable with.Supply, DemandMorgan Stanley, as the named adviser to the designated market maker, will be constantly trying to get a sense of supply and demand for the shares to advise on that opening price. The bank’s team includes global head of technology capital markets, Colin Stewart, as well as David Chen, who leads software banking. John Paci, the co-head of U.S. equities trading, will help advise the designated market maker on where the stock should open based on buying and selling interest gleaned from investors, according to people familiar with the details.At Goldman Sachs, the work will be led by Nick Giovanni, co-head of the global technology, media and telecommunications group, equity capital markets head David Ludwig and Will Connolly, co-head of the West Coast financing group and head of technology ECM.One thing Slack’s listing will have in common with an IPO: executives including Chief Executive Officer Stewart Butterfield and finance chief Allen Shim are expected to be pacing the floor of the NYSE for the open. They may not stick around all day, though. They will likely spend some time at the offices of their advisers before celebrating with employees and customers, according to a person with knowledge of the matter.Representatives for Slack, Goldman Sachs, Morgan Stanley and Citadel Securities declined to comment.Private FundsSlack’s decision to bypass a traditional IPO -- and the opportunity it brings to raise funds -- is yet another sign of how benevolent private markets have been to tech startups in recent years. Slack’s earliest major investor, venture capital firm Accel, has directed a fire hose of money at the messaging company over the years, investing from several of its funds to accumulate a 23.8% stake.In addition to Accel, Slack captured the imagination of elite investors such as Andreessen Horowitz and Social Capital. But it was SoftBank Group Corp.’s behemoth Vision Fund, which also owns stakes in Uber and WeWork Cos., that accelerated Slack’s fundraising when it led a $250 million investment in 2017.One of the main reasons that Slack has remained well capitalized, however, is that it burns through less cash than some of SoftBank’s other investments. Uber, for instance, accumulated more than $10 billion in operating losses in three years. While Slack expects higher-than-usual losses in the second quarter, that still amounts to only about $75 million to $77 million for the three months, even including expenses related to the listing.Growth vs. ProfitabilityThe high demand for IPOs by the likes of money-losing companies including Uber, Lyft Inc. and Beyond Meat Inc. proves that investors remain focused on growth prospects over profitability –- in the short term at least.With Uber leading the pack with its $8.1 billion offering, 79 companies have raised $28.88 billion in U.S. IPOs this year, according to data compiled by Bloomberg. That includes five other listings topping $1 billion, including the $2.34 billion IPO by Uber’s ride-hailing rival Lyft.With no lock-up period for a direct listing, Slack investors could be jittery about any updates from the company, perceived competitive threats or other risks.Tiny SpeckIn its filings, Slack has warned investors that it’s a relatively new business, launching only in 2014 after existing for several years as a gaming company called Tiny Speck. Its rocket-ship ascent has attracted plenty of investors, but gives new potential shareholders only a limited trajectory to study.Another challenge for Slack is one that fellow mega startups like Uber have grappled with, namely whether they can move beyond the core offering that their early years of success were built on. While Slack has improved its product so that it can serve larger companies, many customers still consider it an easy-to-use, aesthetically pleasing workplace messaging platform, despite speculation that it could evolve into a catch-all portal for business applications.One thing that could make Slack’s debut more unpredictable than Spotify’s is its investor base. Because the company’s ownership is more concentrated among fewer, larger shareholders, it could be more difficult to gauge the supply of shares that are likely to be traded, one person with knowledge of the process said. Both buyers and sellers may also hang back on day one to see how trading goes before getting involved: Just 30 million of Spotify shares changed hands in its trading debut, less than a third of the total available.\--With assistance from Crystal Tse and William Hobbs.To contact the reporters on this story: Eric Newcomer in San Francisco at firstname.lastname@example.org;Sonali Basak in New York at email@example.com;Ellen Huet in San Francisco at firstname.lastname@example.orgTo contact the editors responsible for this story: Mark Milian at email@example.com, ;Michael J. Moore at firstname.lastname@example.org, Elizabeth Fournier, Michael HythaFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
For all the headlines it caused, the two-day outage at Target (NYSE:TGT) checkouts barely registered with investors.Source: Mike Mozart via Flickr (Modified)All told, TGT stock lost about 1.5% in the past two days, after thousands of people abandoned their shopping carts and just walked out of stores over the weekend.The cash register outage came just a month after stellar earnings sent the stock shooting upward, from barely $70 per share on May 16 to nearly $90 per share a month later. The company in May said same-store sales grew 4.8% on 4.3% comparable traffic growth for the three months ending in April.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSince then, Target has gone from strength to strength. It raised the dividend slightly, re-launched its in-house media company as Roundel, and announced same-day delivery through Shipt, a grocery delivery service acquired in 2017. Macro vs. Micro for TargetUnlike the massive 2013 data breach that eventually cost CEO Gregg Steinhafel his job in 2016, the two-hour outage on June 14 was seen as a problem caused by regular maintenance. A second, smaller problem processing credit cards on Father's Day was blamed on vendor NCR (NYSE:NCR). * 7 Value Stocks to Buy for the Second Half Rather than attack Target as negligent, most analysts chose to focus on how any company could be hit by such problems, given how dependent they are on giant, interconnected computing systems. There was a sigh of relief that no Target customer data was lost.Target's strategy under current CEO Brian Cornell has been to match its larger rivals in technology but differentiate itself with smaller stores inside urban centers, something Walmart (NYSE:WMT) abandoned earlier in the decade.While the fallout from the tech outage is likely to be brief, Target shares will be hit by general market turbulence. Consider that the Morgan Stanley (NYSE:MS) business conditions index is forecasting a recession ahead.A spike in jobless claims and a bad employment report for May are far more likely to impact Target shares or rivals like Walmart and Kroger (NYSE:KR) than the weekend's problems. Wait for ItIn general, conditions at stores like Target, once called "discount" stores, have been improving. Sales for May are up 3.2% year-over-year. While shopping malls continue to dwindle, stand-alone discounters like Target continue to rack up gains.Historians will note that Target itself emerged from the now-defunct Dayton-Hudson department store chain. The remaining stores rebranded as Marshall Field's and became part of what's now Macy's (NYSE:M) in 2005.Target, meanwhile, has been called Walmart's primary competitor. Even though the Arkansas-based chain is more than seven times its size, Target is more profitable. It brought $3 billion out of $75 billion in sales last year to the net income line. Compare that to $6 billion on $514 billion for Walmart. Despite this, and a dividend yielding 3.1% after its latest raise, Target currently sells for just 15 times trailing earnings. That's less than half Walmart's figure. Both are worth about 60 cents for each dollar of sales. The Bottom Line on TGT StockThe macro news is bound to overwhelm the micro news in the short term. Target's glitch is being treated as just that and, sadly, isn't a buying opportunity.If the economy doesn't collapse, Target under CEO Brian Cornell is in good shape, and a bargain for investors seeking income. If there is a recession, Target is well-positioned to get through it, but you might want to wait to see how deep the current fear goes before jumping in.Dana Blankenhorn is a financial and technology journalist. He is the author of a new environmental story, Bridget O'Flynn and the Bear , available now at the Amazon Kindle store. Write him at email@example.com or follow him on Twitter at @danablankenhorn. As of this writing he owned shares in AMZN. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Value Stocks to Buy for the Second Half * 7 Hot Stocks to Buy for a Seemingly Sleepy Summer * 6 Chip Stocks Staring At Big Headwinds in 2019 Compare Brokers The post The Target Stock Dip Was Barely a Blip appeared first on InvestorPlace.
(Bloomberg) -- Terms of Trade is a coming daily newsletter that untangles a world embroiled in trade wars. Sign up here. Apple Inc. has asked its largest suppliers to consider the costs of shifting 15% to 30% of its output from China to Southeast Asia in a dramatic shake-up of its production chain, the Nikkei reported.The U.S. tech giant asked “major suppliers” to evaluate the feasibility of such a migration, the newspaper cited multiple sources as saying. Those included iPhone assemblers Foxconn Technology Group, Pegatron Corp. and Wistron Corp., MacBook maker Quanta Computer Inc., iPad maker Compal Electronics Inc. and AirPod makers Inventec Corp., Luxshare-ICT and GoerTek Inc., Nikkei cited them as saying.China is a crucial cog in Apple’s business, the origin of most of its iPhones and iPads as well as its largest international market. But President Donald Trump has threatened Beijing with new tariffs on about $300 billion worth of Chinese goods, an act that would escalate tensions while levying a punitive tax on Apple’s most profitable product. Company spokeswoman Wei Gu didn’t respond to a request for comment.Two major Apple suppliers pushed back against the Nikkei report. The U.S. company has not asked for cost estimates for shifting production out of the world’s No. 2 economy, although suppliers are running the numbers on their own given the trade dispute, said one person familiar with the matter, asking not to be identified discussing internal deliberations. Another supplier said it too had not gotten such a request from Apple and that the Cupertino, California-based company had resisted a proposed production shift to Southeast Asia.Apple does have a backup plan if the U.S.-China trade war gets out of hand: Primary manufacturing partner Hon Hai Precision Industry Co. has said it has enough capacity to make all U.S.-bound iPhones outside of China if necessary, Bloomberg News reported last week.The Taiwanese contract manufacturer now makes most of the smartphones in the Chinese mainland and is the country’s largest private employer. Hon Hai, known also as Foxconn, has said Apple has not given instructions to move production but it is capable of moving lines elsewhere according to customers’ needs.Apple hasn’t set a deadline for the suppliers to finalize their business proposals, but is working together with them to consider alternative locations, the Nikkei said. Any move would be a long-term process, it cited its sources as saying.Beyond Apple’s partners, the army of Taiwanese companies that make most of the world’s electronics are reconsidering a reliance on the world’s second-largest economy as Washington-Beijing tensions simmer and massive tariffs threaten to wipe out their margins. That in turn is threatening a well-oiled, decades-old supply chain.Taiwan’s largest corporations form a crucial link in the global tech industry, assembling devices from sprawling Chinese production bases that the likes of HP Inc. and Dell then slap their labels on. That may start to change if tariffs escalate, an outcome now in the balance as Washington and Beijing spar over a trade deal.Apple is an outsized figure in that negotiation. The high-end iPhone, which accounted for more than 60% of the company’s 2018 revenue, drives millions of jobs across China as well as a plethora of different industries from retail to electronics. The country is also a major consumer market in its own right, yielding nearly 20% of last year’s revenue -- weakness there pushed Apple to cut its sales forecast in January.“Twenty-five percent of our production capacity is outside of China and we can help Apple respond to its needs in the U.S. market,” Hon Hai board nominee and semiconductor division chief Young Liu told an investor briefing in Taipei last week. “We have enough capacity to meet Apple’s demand.”(Updates with a source’s comments from the second parapraph.)To contact the reporter on this story: Debby Wu in Taipei at firstname.lastname@example.orgTo contact the editors responsible for this story: Peter Elstrom at email@example.com, Edwin ChanFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
Disney is a stock that Wall Street is laser-focused on as the entertainment powerhouse prepares to launch its streaming TV platform in the fall. So is it time to buy DIS stock at new highs?
(Bloomberg Opinion) -- Expect “Pig-gate” to blow over. UBS Group AG’s ultra-rich Chinese clients are unlikely to desert the Swiss bank for local rivals, whatever the level of outrage over language used by its chief economist in a research report last week.The bank's potential loss of Chinese share-sale mandates isn’t a critical blow: UBS ranks a distant 11th in underwriting Hong Kong IPOs in 2019. (The bank fell behind after a one-year ban by the Securities and Futures Commission over deficiencies in its work on three companies that ran into trouble after listing.) Nor is the loss of bond mandates, such as its exclusion from a sale by state-owned China Railway Construction Corp.Wealth management is different. UBS is vying for a share of a Chinese private-banking market that was worth a record $24 trillion in 2018, according to Boston Consulting Group. The furor among local brokerages over UBS’s use of “Chinese pig” in a report on pork supply and inflation comes just as the Swiss firm and other foreign banks are muscling in on their turf. Switzerland’s Credit Suisse Group AG, Japan’s Nomura Holdings Inc., and Wall Street giants JPMorgan Chase & Co. and Morgan Stanley are among firms that have received approval to expand or are working toward taking majority stakes in China ventures.On top of that, Chinese regulators have cracked down on high-risk wealth management products sold by local banks and brokerage firms. That’s leveled the playing field for overseas competitors, which say their stricter compliance guidelines wouldn’t allow them to offer such investments.Still, it’s outside China where UBS has most to protect. Like all foreign banks, it’s a minnow in the mainland market. By contrast, there’s a treasure trove of Chinese money being managed offshore in cities such as Hong Kong, Singapore and New York, according to a survey by consulting firm Capgemini SE last year. Boston Consulting reckons that market is worth $1 trillion. And here, UBS is hard to beat.At the end of last year, the Zurich-based bank had $152 billion more in assets under management in Asia outside mainland China than Credit Suisse, its nearest rival. Chinese players don’t rank in the top 10 for bankers to well-heeled individuals in the region, according to data from Asian Private Banker.UBS took in an unprecedented $16 billion in net new money in the first quarter, driving its Asia-Pacific assets to $405 billion. Credit Suisse collected the equivalent of $4.4 billion. UBS was also the region’s top equities trading house in the region last year, ahead of Morgan Stanley and JPMorgan, according to data from London-based analytics firm Coalition Development Ltd. It’s been Asia’s No. 1 equities house since 2010. That’s key for high-net-worth individuals looking for ideas to trade on.Money tends to flow to where it earns the most, other things being equal. Also, many clients have bought derivatives from UBS, which can’t be unwound at short notice without heavy penalties. UBS can console itself with the thought that other foreign banks have been able to ride out similar difficulties in Asia. Time is on its side. To contact the author of this story: Nisha Gopalan at firstname.lastname@example.orgTo contact the editor responsible for this story: Matthew Brooker at email@example.comThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Nisha Gopalan is a Bloomberg Opinion columnist covering deals and banking. She previously worked for the Wall Street Journal and Dow Jones as an editor and a reporter.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
Investment funds managed by Morgan Stanley Capital Partners (MSCP), announced today that they have completed an investment in Project Management Academy (“PMA” or the “Company”), a leading provider of training and exam preparation services for project management professionals. MSCP is partnering with the current CEO, Jason Cassidy, and the rest of the management team, who will remain in place and retain an equity stake in the business. Project Management Academy was founded in 2009 to provide best-in-class training for the career-critical Project Management Professional (PMP)® certification.
Value stocks are so out of fashion at the moment that despite being cheaper than they've been in the past 30 years, some experts suggest they're still not the stocks to buy."We could've had this story 10 years ago and talked about the 20-year anniversary of it being a bad market for value," Dave Nadig, managing director of ETF.com, said recently on CNBC. "We could go another 10 years and it could be a bad market for value. I'm not sure that value and growth as an investing paradigm makes that much sense anymore."Another expert who appeared on the same CNBC show as Nadig suggested that you should only buy value stocks heading into a recession or in the first year coming out of one. InvestorPlace - Stock Market News, Stock Advice & Trading TipsUntil either of these situations comes around, Datatrek Research co-founder Nick Colas believes investors ought to stick with growth stocks.I say, not so fast. * 5 Stocks to Buy for $20 or Less I'll select seven stocks to buy for the second half of 2019, all from the top 50 holdings of the Vanguard Value ETF (NYSEARCA:VTV), the biggest value ETF in the U.S. with $48 billion in assets under management. Value Stocks to Buy: Berkshire Hathaway (BRK.A, BRK.B)Source: Shutterstock Berkshire Hathaway (NYSE:BRK.A, NYSE:BRK.B) is the largest of the 338 holdings in VTV with a weighting of 5.6%. Warren Buffett's company continues to have a bad year on the markets, up just 2.2% year to date.However, when you consider that Berkshire had a total return of 3% in 2018, Buffett's working on a 17-month losing streak. That's why I recently provided InvestorPlace readers with seven ideas to make Berkshire Hathaway stock more attractive. I'm as enamored with the holding company as the next person, but it is having a hard time convincing investors who've never owned its stock why they should get on board. With all the talk of it underperforming the S&P 500 in recent years, its sum-of-the-parts valuation still makes it one of the best value stocks to buy inside or outside the index. Long-time investors know this, hence why they continue to hold despite going into a second year of single-digit returns. Also, it's essential to add that its poor performance in 2018 was 739 basis points higher than the index. Verizon (VZ)Source: Shutterstock Verizon (NYSE:VZ) is the 10th-largest of VTV's 338 holdings with a weighting of 1.9%. The second-largest wireless carrier in the U.S. is having a bad year, up just 4% year to date. Worse still, VZ stock is getting pulverized by AT&T (NYSE:T), which is up 14% year to date.In late May, I highlighted the reasons why I thought Verizon was a better buy than T stock.For me, it all comes down to the balance sheet. Verizon's is much healthier due to AT&T's massive purchase of WarnerMedia. AT&T supporters might view Verizon's advantage as a temporary one given HBO's future cash flow generation -- and I get that argument. However, because AT&T has long-term debt that's 71% of its market cap compared to 45% for Verizon -- with price-to-cash flow ratios almost identical -- if I'm a value investor, I have to go with the smaller of the two companies. * 7 Top-Rated Biotech Stocks to Invest In Today AT&T might deliver in the long haul, but the bigger margin of safety lies with Verizon. Caterpillar (CAT)Source: Anthony via FlickrCaterpillar (NYSE:CAT) is the 37th-largest of VTV's holdings with a weighting of 1.1%. The maker of heavy equipment for mines and construction is also having a bad year, up just 4.5% year to date through June 12. That's on top of a 17.3% decline in 2018.The problem for Caterpillar is that the construction industry, its most significant revenue source, could be slowing down. Furthermore, the Asia/Pacific market isn't performing well, and that's got investors worried about the future. As a result of these worries, Caterpillar stock lost more than 14% in May. The issues plaguing CAT stock at the moment have little to do with the company itself and more to do with the global economy. It's something that shareholders can't control. However, with a dividend yield of 3.1%, free cash flow of $4 billion, a free cash flow yield of 3.9%, and a forward P/E of 10.1, CAT stock appears to be trading at below fair value, making a bet on its stock a winning one over the long haul. Morgan Stanley (MS)Source: Shutterstock Morgan Stanley (NYSE:MS) is the 52nd-largest of VTV's 338 holdings with a weighting of 0.82%. The global investment bank is having a decent year, up 11% year to date. When Morgan Stanley reported Q1 2019 results in April, they were nothing to write home about. That said, both its revenue and profits beat analyst expectations. The consensus was for earnings of $1.17 a share on $9.94 billion in revenue. MS delivered $1.39 a share in earnings on $10.3 billion in revenue. More importantly, the company's wealth management business, the company's largest, delivered revenues of $4.39 billion in the quarter, $200 million higher than the estimate. Since taking the reins, CEO James Gorman has focused Morgan Stanley on wealth management and that's ensuring it continues to generate significant revenues and profits. * 10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019 Yielding 2.8% and trading at 8.1 times forward earnings, MS stock is cheaper than a lot of the mainline banks. CVS Health (CVS)Source: Mike Mozart via FlickrCVS Health (NYSE:CVS) is the 40th-largest of VTV's 338 holdings with a weighting of 0.94%. Both CVS and its biggest competitor, Walgreens Boots Alliance (NASDAQ:WBA), are having terrible years on the market. CVS and WBA are down 16% and 22% year to date. CVS has been bogged down getting approval from regulators for its $69 billion takeover of Aetna in November. The retail pharmacy chain is transforming its business into a one-stop shop for health and wellness. Aetna's insurance plans will allow CVS to provide its customers with vertically integrated medical care. A report surfaced June 11 that suggested the federal court judge considering whether to allow the merger is leaning toward blocking it from happening. However, CVS strenuously denied that the rumor had any merit. I like CVS' transformation plan and fully expect the deal to go through. Trading at just 7 times cash flow and 8 times forward earnings, CVS is too cheap to ignore. Walt Disney (DIS)Source: Baron Valium via FlickrWalt Disney (NYSEDIS) is the 24th-largest of VTV's 338 holdings with a weighting of 1.56%. After three sub-par years in the markets -- up 0.6%, 4.7%, and 3.6% in 2016 through 2018 -- DIS stock is delivering like gangbusters for shareholders, up 30.2% year to date.I was a fan of Disney before it closed its $71-billion acquisition of 21st Century Fox and I'm still a fan. That being said, I did suggest in March that the Fox deal would do little to boost the company's share price. My feeling is that we won't be able to quantify the success of the deal for at least 3-5 years. In the meantime, Disney's going to be spending like a drunken sailor to ensure Disney+ is a Netflix (NASDAQ:NFLX) killer. I'm facetious, of course. No one, not even the world's largest entertainment company, is going to take Reed Hastings down. At least not overnight. InvestorPlace's Tom Taulli recently wrote a great piece about Disney and artificial intelligence. I recommend you read it. For me, Taulli's article exemplifies why you should own Disney stock -- its use of technology to entertain people is the best on the planet. * 7 High-Quality Cheap Stocks to Buy With $10 Disney's got a lot of moving parts and Bob Iger and the rest of its management team will continue to do what it takes to remain the world's biggest and best entertainment company. It's not dirt cheap, but it's worth every penny. PepsiCo (PEP)Source: Shutterstock PepsiCo (NYSE:PEP) is the 17th-largest of VTV's 338 holdings with a weighting of 2.4%. Since long-time CEO Indra Nooyi stepped down in October, Pepsi stock is up 26.7%, an annualized total return of 40%.Before you get any ideas Nooyi was holding back PepsiCo stock; she delivered a cumulative total return of 136% over 17 years in the top job, including a significant stretch through the 2008 recession which saw PEP stock drop to below $20. The work she did to get the beverage and snack food maker in fighting form in recent years helped her successor, Ramon Laguarta, hit the ground running. Laguarta joined Pepsi Europe in 1996, moving up the ranks until becoming PepsiCo president in September 2017; ascending to the top role when Nooyi retired a year later. Nooyi built an exceptional bench of talent. Case in point: PepsiCo chief commercial officer Laxman Narasimhan just took the CEO job at Reckitt Benckiser (OTCMKTS:RBGLY) -- whose brands include Lysol, Woolite, Calgon, Scholl and Clearasil -- less than three months after being appointed to the newly created role at Pepsi. Pepsi reached on to its deep bench to appoint Ram Krishnan to replace Narasimhan. Krishnan currently runs the company's Greater China business. Trading near a 52-week high of $134.71, PepsiCo stock looks ready to continue moving higher. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 5 Red-Hot IPO Stocks to Buy for the Long Run * 5 Stocks to Buy for $20 or Less * 4 Dow Jones Stocks Ready to Rise Compare Brokers The post 7 Value Stocks to Buy for the Second Half appeared first on InvestorPlace.
Morgan Stanley NYSE:MSView full report here! Summary * Perception of the company's creditworthiness is neutral * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for MS with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MS. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding MS are favorable, with net inflows of $6.60 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Financials sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. MS credit default swap spreads are within the middle of their range for the last three years.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues:
(Bloomberg) -- Pfizer Inc. will buy Array BioPharma Inc. for $10.6 billion to gain its promising new medicines for cancer, which could end or limit the use of punishing chemotherapy for some patients.The agreed price of $48 in cash is 62% above Array’s close last Friday -- already a record high. The company’s shares have soared thanks to drugs that target a mutation that’s found across a wide variety of tumor types, and could be used in treating a broad set of cancers in patients who carry the mutation. Array’s drugs, Braftovi and Mektovi, are already approved in the U.S. for use in advanced melanoma.Pfizer said in a statement that it will get royalties from the uses of drugs that Array has licensed out to other companies. It will acquire a pipeline of drugs in development, as well as future revenue from Braftovi and Mektovi in some other malignancies, such as colon cancer.Array shares rose 58% in to $46.67 at 9:32 a.m. in New York. Pfizer was little changed.Cancer has become one of the hottest areas for deal activity between drug and biotechnology companies. Research efforts dating back decades have helped scientists understand how genetic mutations cause some cancers to grow, and other scientific advances have helped them learn how tumors evade the body’s defenses. That knowledge has created an array of targets for drugmakers to attack, leading to new tailored therapies often defined by a tumor cell’s specific biology rather than its location in the body.Unlike other biotech stocks, many of which have pulled back from recent 2018 highs, Array’s shares have been on a steady march upward. The stock was already at a record before the deal announcement, following Array’s news last month of positive clinical trial results using Braftovi and Mektovi with Eli Lilly & Co.’s Erbitux. That combination could be the first chemotherapy-free regimen for some patients who have advanced colon cancer.Array’s drug targets a mutation called BRAF, which can show up in some forms of melanoma, colorectal and thyroid cancers, among others. Other drugs on the market target that mutation as well. Roche Holding AG’s Zelboraf is projected to bring in $168.7 million this year, according to a survey of analysts compiled by Bloomberg. Novartis AG’s Tafinlar is used in combination with another drug Mekinist, and the combination is expected to bring in $1.24 billion this year, according to analysts.The deal could also boost other biotech stocks, especially companies with drugs in the later stages of development that could be appetizing for big drugmakers. “We expect this announcement to provide a tailwind for the sector,” said Stephen Willey, an analyst with Stifel Nicolaus & Co. He called the premium for the Array deal appropriate, given the company’s positive clinical trial news.The deal is Pfizer’s biggest since its 2016 acquisition of Medivation for $14 billion, another blockbuster cancer deal that the New York-based company used to expand its oncology offerings. With that takeover, Pfizer gained Xtandi, a prostate cancer drug that last year Xtandi brought it $699 million.“From an overall capital allocation perspective, our priorities don’t change,” Pfizer Chief Financial Officer Frank D’Amelio said on a conference call Monday. The company will continue to look at dividends, buybacks and small or mid-size deals, and doesn’t see the need for a large merger, he said. Pfizer has lagged behind drugmakers like Merck & Co. and Bristol-Myers Squibb Co. that have brought to market best-selling drugs that use the immune system to attack tumors. But the company has acquired or developed a set of other treatments for breast, prostate other cancers that target disease based on its biological profile. Such methods can result in more effective drugs, fewer side-effects, or both.Pfizer plans to fund the deal with a combination of debt and cash. It said it expects the deal to close in the second half of this year. The deal comes with a $400 million termination fee, according to a regulatory filing by Array.Guggenheim Securities and Morgan Stanley & Co. served as Pfizer’s financial advisers, and Wachtell, Lipton, Rosen & Katz gave legal advice. Centerview Partners was Array’s financial adviser, and Skadden, Arps, Slate, Meagher & Flom LLP served as its legal adviser.(Updates with analyst comment in seventh paragraph. An earlier version of this story corrected the description of Pfizer’s advisers in the final paragraph.)\--With assistance from Marthe Fourcade and Cynthia Koons.To contact the reporter on this story: Drew Armstrong in New York at email@example.comTo contact the editors responsible for this story: Drew Armstrong at firstname.lastname@example.org, Cécile DauratFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
(Bloomberg) -- This year’s global stock rally has flown in the face of billions of dollars of outflows, mounting fears for economic growth, and most recently a bombardment of geopolitical shocks.But it might not be as defiant -- or as crazy -- as it seems.As a gauge of global shares looks to extend two weeks of gains, there’s mounting evidence that beneath the surface equity investors have been getting smart. Far from ignoring brewing risks, they’re increasingly positioned for bad news, bidding up defensive and quality companies at the expense of those more exposed to the economic cycle.It all challenges the narrative that the stock markets have paid no heed to the warnings screamed by global bonds, or that they are simply counting on accommodative central bankers to juice asset prices.“People are bracing for a bear market,” said Brian Jacobsen, a senior investment strategist of multi-asset solutions at Wells Fargo Asset Management, which oversees $476 billion. “Not predicting it. Just trying to be prepared.”As traders favor firms that can weather a potential downturn, the valuation discount of value to growth stocks has surged to the widest since 2001. The Goldman Sachs Group Inc. gauge of high quality shares is outperforming the S&P 500 Index this month. And the Russell 2000 Index of small caps is trading near the biggest discount versus the Russell 3000 Index since at least 2006.The extremity of this push into safer equities has seen the likes of Morgan Stanley warn about a “big unwind’’ if their performance stumbles. Riskier shares attempted a comeback last month, with weak balance sheet stocks in the U.S. outperforming peers with strong balance sheets.But the trend didn’t last. In June, investors are once again rewarding companies flush with cash and low debt, lifting their premium over those with less attractive financial profiles to near a record high.“Valuations don’t matter too much until they get to eye-watering extremes,” said Jacobsen. “I don’t think that they’re at eye-watering extremes” for defensive shares, he said.Momentum stocks have been another winner from the search for a place to hide, with the investing style outperforming value shares by a near-record 17% in May. They have continued beating cheaper stocks this month due to a strong overlap with quality and low-volatility equities, according to Morgan Stanley.At essence, stock investors appear to be trying to hedge their bets between two major outcomes. On the one hand, they’re staying invested on the prospect of an extension of the business and economic cycle, perhaps prolonged by a trade war breakthrough or central bank largess. On the other, they’re opting for safe shares in case the U.S.-China protectionist battle drags out or escalates, derailing global growth.“The correct positioning is not obvious and it’s a tough call,” said Edward J. Perkin, chief equity investment officer at Eaton Vance Management. “With the equity market near all-time highs, do you take economic risk by owning cyclicals, or valuation and interest rate risk by buying defensive sectors at high prices?”Perkin favors a middle ground: He likes companies with solid financials, though he’s focused on economically sensitive sectors that can outperform if growth remains strong. And he cautions that not all defensive sectors are attractive, warning against expensive yield-sensitive sectors and consumer staples due to their financial leverage and muted revenue growth.Meanwhile major asset managers like Wells Fargo Asset Management and Legal & General Investment Management say they now prefer a neutral stance, allowing them to easily maneuver depending on whether the U.S. strikes a trade deal with China or global growth falters.One thing the money managers all agree on: Despite seeing a need for caution, they’re not yet ready to call the end of this bull market.“It still may be too early to call the peak,” said Nick Alonso, director of the multi-asset group at PanAgora Asset Management. “I believe that, especially in uncertain times like these, focusing on portfolio construction as a means of achieving diversification through proper risk balancing can be a very powerful tool.”\--With assistance from Justina Lee.To contact the reporter on this story: Ksenia Galouchko in London at email@example.comTo contact the editors responsible for this story: Blaise Robinson at firstname.lastname@example.org, Samuel Potter, Jeremy HerronFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
Morgan Stanley Wealth Management today announced the launch of a new suite of Impact Portfolios with a $10,000 minimum on its Investing with Impact platform. The six Portfolios utilize a range of Investing with Impact objectives including restriction screening, environmental, social and governance integration, and thematic investing. The Impact Portfolios leverage Wealth Management Investment Resources’ intellectual capital including: asset allocation advice, portfolio construction resources, manager analysis, risk management and ongoing portfolio monitoring to provide clients with a diversified multi-asset class portfolio.
Investment funds managed by Morgan Stanley Capital Partners , the middle market focused private equity team within Morgan Stanley Investment Management, announced today that they have completed an investment in Ovation Fertility .
(Bloomberg Opinion) -- UBS Group AG has managed to alienate an important client that it’s hoping to milk for millions in fees.State-owned China Railway Construction Corp. has decided against hiring UBS as a joint global coordinator on a dollar-bond sale, Cathy Chan of Bloomberg News reported Monday. Haitong International Securities Group Ltd. has already cut business ties with the Swiss bank, while the Securities Association of China recommended members shun research by global chief economist Paul Donovan over language used in a research report last week.At issue were Donovan’s comments on the rise of inflation in China:“Does this matter? It matters if you are a Chinese pig. It matters if you like eating pork in China. It does not really matter to the rest of the world.”Two debates ensued. The first is whether Donovan’s words are offensive and racist. Even linguists are chiming in. The second is whether U.S. President Donald Trump’s administration is right after all: Is doing business in China more perilous for foreign firms? Will Beijing continue to protect domestic players despite its vows to open up?As a native Chinese speaker, I don’t find Donovan’s comments racist, and certainly didn’t draw a connection with the pejorative term for Chinese laborers who built U.S. railroads in the 19th century. Rather, I find his choice of words unfortunate, and perhaps insensitive, given UBS is keen on luring wealthy Chinese clients.Bear in mind that 2019 is the Year of the Pig, which is supposed to be bountiful and abundant. Yet the nation, where pork remains the main source of animal protein, is suffering from a swine fever epidemic. To make matters worse, this year is shaping up to be another painful one for the economy: Growth is losing steam, despite Beijing’s trillion-yuan stimulus package, and the stock market is now in correction zone. Donovan’s comments were inauspicious, at a time when Chinese investors are already in a foul mood. I’d be willing to bet that we Chinese would better absorb his dry humor if the nation’s economic engine was running at full steam. You could say that China’s response has been a bit heavy-handed. But tough luck. It’s called the cost of doing business in emerging markets, and China is by no means an exception. Foreign banks have gotten into just as much trouble for lesser offenses. Two examples in the recent past come to mind.Andy Xie, an MIT-trained star economist, left Morgan Stanley in 2007 after an email he wrote citing “money laundering” as one reason for Singapore’s economic success. Never mind that it was an internal message. Donovan’s published report, meanwhile, presumably went through the requisite compliance hoops. Xie had disparaged Singapore, an Asian Tiger. Or consider what happened to JPMorgan Chase & Co. in Indonesia. In 2017, the government severed business ties with the bank, eliminating its role as a primary dealer in sovereign-bond auctions. That came after its research division downgraded the nation’s stocks to underweight, citing a “spike in volatility” following Trump’s surprise election win. The response also punished investment bankers for equity research, despite the well-established split between the businesses. That penalty certainly hurt: Indonesia is a mover and shaker in the bond world, with close to 40% of its sovereign issues taken up by foreigners.For UBS, even bigger asset-management fees are at stake. Unlike in the U.S., where passive funds now dominate, China is the last big market on earth where investors still have faith in active managers. That explains why global banks are falling over themselves to bulk up there.When I wrote about this in April, I warned that domestic brokers wouldn’t leave the field to the foreign “barbarians.” A cynic could ask about the conflict of interest apparent in Pig-Gate. After all, core members of the Chinese Securities Association of Hong Kong, which demands Donovan’s dismissal, and the Securities Association of China, which aims to block out UBS, compete with the Swiss bank for China money. In that light, the outcome with Haitong isn’t all that surprising. At the end of the day, beggars can’t be choosers. With its investment-banking business falling behind that of U.S. mega banks and Swiss rival Credit Suisse AG, UBS needs its wealth-management business. In that case, it had better start doing more to please a moody client.To contact the author of this story: Shuli Ren at email@example.comTo contact the editor responsible for this story: Rachel Rosenthal at firstname.lastname@example.orgThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Shuli Ren is a Bloomberg Opinion columnist covering Asian markets. She previously wrote on markets for Barron's, following a career as an investment banker, and is a CFA charterholder.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
Investing.com - In what is set to be a busy week, the Federal Reserve’s latest interest rate announcement will dominate trader’s attention amid expectations that the central bank could flag plans to ease monetary policy.
After two years of surging payouts as regulators relaxed the reins on the biggest lenders, those firms are likely to boost dividends and buybacks by just 3% following this year’s stress test, according to analysts’ estimates compiled by Bloomberg. The Federal Reserve will release results of the first part of its annual review next week. Payouts to shareholders started to ramp up in 2016 after the Fed was satisfied that the largest lenders had adequately beefed up loss buffers and improved risk management.
On June 14, the broader market is likely to open on a negative note after closing in the green yesterday. Today at 7:00 AM EDT, S&P 500 Index futures, Nasdaq futures, and Dow futures were trading with 0.3%, 0.8%, and 0.2% losses for the day, respectively.
U.S. stock futures are trading slightly lower ahead of the bell. In early morning trading, futures on the Dow Jones Industrial Average are down 0.16%, and S&P 500 futures are lower by 0.23%. Nasdaq-100 futures have shed 0.63%.In the options pits, fear officially left the building, at least if put volumes are any indication. They sank to their lowest levels in recent memory. By day's end, only 12.7 million puts changed hands compared to 15.1 million calls.The ebb in put demand was felt at the CBOE as well, with the single-session equity put/call volume ratio slamming back down to 0.63. That places it in the center of the past few months range. Meanwhile, the 10-day moving average held its ground at 0.66.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOptions traders targeted the following three stocks: Lululemon (NASDAQ:LULU), Disney (NYSE:DIS) and Snap (NYSE:SNAP).Let's take a closer look: Lululemon (LULU)A strong earnings report sent Lululemon stock to record highs on Thursday. For the first quarter, the athletic apparel company earned 74 cents per share on revenue of $782 million. Analysts were expecting earnings of 70 cents on $755 million revenue. * 10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019 LULU also raised its full-year guidance to between $3.73 and $3.77 billion in revenue and earnings per share between $4.51 and $4.58.The stock opened 6.5% higher, but sellers erased the bulk of the gains by day's end. That said, Lululemon stock still sits above all its moving averages, and the long-term trend remains healthy as a horse. Wait for a close above the $180 resistance to signal buyers are ready to sustain a breakout.On the options trading front, calls won the day by a modest margin. Total activity rocketed to 744% of the average daily volume, with 128,810 contracts traded. Calls claimed 56% of the tally.The post-earnings volatility crush was on full display, sending implied volatility into the basement. At 29%, it now sits at the 19th percentile of its one-year range. Premiums are now pricing in daily moves of $3.16, or 1.8%. Disney (DIS)The mouse house was rockin' Thursday after receiving some love from Morgan Stanley analyst Benjamin Swinburne. By day's end, DIS stock rose 4% bringing it within a whisker of a new record high.In the research piece, the bank raised their price target for DIS shares from $135 to $160 citing a lofty forecast for the number of subscribers buying into Hulu, Disney Plus, and ESPN Plus. By 2024, the firm thinks the number could rise as high as 130 million, which should deliver a substantial boost to Disney's bottom line.On the options trading front, traders came after calls with a vengeance. Activity swelled to 516% of the average daily volume, with 372,538 total contracts traded. 85% of the trading came from call options alone.The uptick in demand drove implied volatility higher to 29%, placing it at the 29th percentile of its one-year range. Premiums are now baking in daily moves of $2, or 1.4%. Snap (SNAP)The news was light for Snap shares, but that didn't keep traders from gobbling up call options on the surging social media stock. The 2019 recovery accelerated this month with a rousing two-month breakout that has lifted SNAP stock just shy of a new 52-week high.Volume patterns are supporting the bulls' campaign with multiple accumulation days cropping up. The past five days have seen tight consolidation form near resistance. The lack of any giveback after last week's rip-roaring rally is impressive and reveals the continued strength of buying beneath the surface.On the options trading front, calls proved far more popular than puts. Total activity grew to 155% of the average daily volume, with 143,455 contracts traded. Calls accounted for 71% of the session's sum.Uncertainty has dwindled dramatically with implied volatility now down to 48%. That places it at the 13th percentile of its one-year range, suggesting premiums are quite cheap. The expected daily move is now 43 cents, or 3%.As of this writing, Tyler Craig held bullish options positions in DIS. Check out his recently released Bear Market Survival Guide to learn how to defend your portfolio against market volatility. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019 * 7 Value Stocks That Are Flying Under the Radar * 6 Mouth-Watering Fast Food Stocks for Growth Investors Compare Brokers The post Friday's Vital Data: Lululemon, Disney and Snap appeared first on InvestorPlace.
Futures in New York ended up 2.2%, paring gains of as much as 4.5% during the session. The U.S. blamed Iran for attacks on two tankers near the Strait of Hormuz chokepoint -- through which about 20% of the world’s oil output travels -- raising the prospect of a military confrontation and supply disruptions in the Middle East. Thursday’s price gain gives bulls a reprieve, as the tanker attacks raised fears that diplomatic efforts won’t avert a armed conflict between Iran and the U.S., which has imposed sanctions on the OPEC member.
The Federal Reserve will leave rates unchanged but has removed its 'patience' in monetary policy. Yahoo Finance's Brian Cheung breaks it down.